newsfilter
← Latest News
Business Wire·

Innate Pharma Files Its 2025 Universal Registration Document (Document D'enregistrement Universel) and 2025 Form 20-f Annual Report

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced the filing of its 2025 Universal Registration Document (Document d'enregistrement universel) for the year ending